1. Home
  2. CSTL vs CGC Comparison

CSTL vs CGC Comparison

Compare CSTL & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$39.29

Market Cap

661.7M

Sector

Health Care

ML Signal

HOLD

Logo Canopy Growth Corporation

CGC

Canopy Growth Corporation

HOLD

Current Price

$1.21

Market Cap

578.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSTL
CGC
Founded
2007
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Medical Specialities
Pharmaceuticals and Biotechnology
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
661.7M
578.3M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
CSTL
CGC
Price
$39.29
$1.21
Analyst Decision
Strong Buy
Hold
Analyst Count
6
2
Target Price
$42.83
N/A
AVG Volume (30 Days)
370.2K
53.7M
Earning Date
11-03-2025
02-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$343,530,000.00
$200,022,256.00
Revenue This Year
$1.69
$6.79
Revenue Next Year
N/A
$7.34
P/E Ratio
N/A
N/A
Revenue Growth
10.15
N/A
52 Week Low
$14.59
$0.77
52 Week High
$42.18
$3.07

Technical Indicators

Market Signals
Indicator
CSTL
CGC
Relative Strength Index (RSI) 58.67 44.98
Support Level $37.76 $1.54
Resistance Level $42.18 $2.38
Average True Range (ATR) 1.20 0.26
MACD -0.35 -0.04
Stochastic Oscillator 46.17 8.91

Price Performance

Historical Comparison
CSTL
CGC

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

About CGC Canopy Growth Corporation

Canopy Growth Corp, cultivates and sells medicinal and recreational cannabis and hemp through a portfolio of brands that include Doja, LivRelief, Ace Valley, Deep Space, and others. The Company is engaged in reportable segments namely: Canada cannabis, International markets cannabis, Storz & Bickel, and This Works. The company generates maximum revenue from Canadian cannabis.

Share on Social Networks: